US value-based care emphasizes paying for outcomes and reducing unnecessary treatment, with the core being alignment of interests between payers and providers; Indian startups, by contrast, focus more on "affordability"—lowering unit costs through standardized clinical pathways, centralized procurement of drugs and consumables, and digital scheduling and medical record management.